LYEL Competitors & Alternatives
Compare Lyell Immunopharma Inc with similar stocks in the same industry
Biotechnology
LYEL
Main Stock$9.39
Tradestie Score
42
Market Cap
$317.95M
Revenue Growth
-0.5%
Analyst Upside
+303.4%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DBVT
DBV Technologies S.A.
|
$9.75
|
$275.54M | - | 63 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$18.26
|
$269.08M | 0.1 | 50 | Compare |
|
PBYI
PUMA BIOTECHNOLOGY INC
|
$11.02
|
$265.45M | 21.0 | 46 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$23.55
|
$256.54M | - | 53 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.67
|
$240.89M | - | 31 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.66
|
$231.77M | - | 49 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$9.58
|
$227.00M | - | 45 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$11.54
|
$211.22M | - | 46 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$3.75
|
$202.58M | - | 64 | Compare |
More LYEL Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry